The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Branded Generics Market Research Report 2025

Global Branded Generics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1417243

No of Pages : 78

Ask Your Query

Synopsis

This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules. 

The global Branded Generics market was valued at US$ 312 million in 2023 and is anticipated to reach US$ 523.1 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Branded Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Branded Generics.

Report Scope

The Branded Generics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Branded Generics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Branded Generics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Mylan NV
  • Novartis AG
  • Eva Pharmaceutical Industries
  • Pfizer
  • Sun Pharmaceutical Industries
  • Aspen Pharmacare Holding
  • Abbott Laboratories
  • Bausch Health

Segment by Type

  • Oral
  • Parenteral
  • Topical
  • Other

Segment by Application

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Branded Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Branded Generics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Branded Generics Market Overview
1.1 Product Overview and Scope of Branded Generics
1.2 Branded Generics Segment by Type
1.2.1 Global Branded Generics Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Topical
1.2.5 Other
1.3 Branded Generics Segment by Application
1.3.1 Global Branded Generics Market Value by Application: (2024-2030)
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Neurology
1.3.6 Gastrointestinal Diseases
1.3.7 Others
1.4 Global Branded Generics Market Size Estimates and Forecasts
1.4.1 Global Branded Generics Revenue 2019-2030
1.4.2 Global Branded Generics Sales 2019-2030
1.4.3 Global Branded Generics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Branded Generics Market Competition by Manufacturers
2.1 Global Branded Generics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Branded Generics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Branded Generics Average Price by Manufacturers (2019-2024)
2.4 Global Branded Generics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Branded Generics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Branded Generics, Product Type & Application
2.7 Branded Generics Market Competitive Situation and Trends
2.7.1 Branded Generics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Branded Generics Players Market Share by Revenue
2.7.3 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Branded Generics Retrospective Market Scenario by Region
3.1 Global Branded Generics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Branded Generics Global Branded Generics Sales by Region: 2019-2030
3.2.1 Global Branded Generics Sales by Region: 2019-2024
3.2.2 Global Branded Generics Sales by Region: 2025-2030
3.3 Global Branded Generics Global Branded Generics Revenue by Region: 2019-2030
3.3.1 Global Branded Generics Revenue by Region: 2019-2024
3.3.2 Global Branded Generics Revenue by Region: 2025-2030
3.4 North America Branded Generics Market Facts & Figures by Country
3.4.1 North America Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Branded Generics Sales by Country (2019-2030)
3.4.3 North America Branded Generics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Branded Generics Market Facts & Figures by Country
3.5.1 Europe Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Branded Generics Sales by Country (2019-2030)
3.5.3 Europe Branded Generics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Branded Generics Market Facts & Figures by Country
3.6.1 Asia Pacific Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Branded Generics Sales by Country (2019-2030)
3.6.3 Asia Pacific Branded Generics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Branded Generics Market Facts & Figures by Country
3.7.1 Latin America Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Branded Generics Sales by Country (2019-2030)
3.7.3 Latin America Branded Generics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Branded Generics Market Facts & Figures by Country
3.8.1 Middle East and Africa Branded Generics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Branded Generics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Branded Generics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Branded Generics Sales by Type (2019-2030)
4.1.1 Global Branded Generics Sales by Type (2019-2024)
4.1.2 Global Branded Generics Sales by Type (2025-2030)
4.1.3 Global Branded Generics Sales Market Share by Type (2019-2030)
4.2 Global Branded Generics Revenue by Type (2019-2030)
4.2.1 Global Branded Generics Revenue by Type (2019-2024)
4.2.2 Global Branded Generics Revenue by Type (2025-2030)
4.2.3 Global Branded Generics Revenue Market Share by Type (2019-2030)
4.3 Global Branded Generics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Branded Generics Sales by Application (2019-2030)
5.1.1 Global Branded Generics Sales by Application (2019-2024)
5.1.2 Global Branded Generics Sales by Application (2025-2030)
5.1.3 Global Branded Generics Sales Market Share by Application (2019-2030)
5.2 Global Branded Generics Revenue by Application (2019-2030)
5.2.1 Global Branded Generics Revenue by Application (2019-2024)
5.2.2 Global Branded Generics Revenue by Application (2025-2030)
5.2.3 Global Branded Generics Revenue Market Share by Application (2019-2030)
5.3 Global Branded Generics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan NV
6.1.1 Mylan NV Corporation Information
6.1.2 Mylan NV Description and Business Overview
6.1.3 Mylan NV Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan NV Branded Generics Product Portfolio
6.1.5 Mylan NV Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis AG Branded Generics Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Eva Pharmaceutical Industries
6.3.1 Eva Pharmaceutical Industries Corporation Information
6.3.2 Eva Pharmaceutical Industries Description and Business Overview
6.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eva Pharmaceutical Industries Branded Generics Product Portfolio
6.3.5 Eva Pharmaceutical Industries Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Branded Generics Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Industries Branded Generics Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Aspen Pharmacare Holding
6.6.1 Aspen Pharmacare Holding Corporation Information
6.6.2 Aspen Pharmacare Holding Description and Business Overview
6.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aspen Pharmacare Holding Branded Generics Product Portfolio
6.6.5 Aspen Pharmacare Holding Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Branded Generics Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Bausch Health
6.8.1 Bausch Health Corporation Information
6.8.2 Bausch Health Description and Business Overview
6.8.3 Bausch Health Branded Generics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bausch Health Branded Generics Product Portfolio
6.8.5 Bausch Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Branded Generics Industry Chain Analysis
7.2 Branded Generics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Branded Generics Production Mode & Process
7.4 Branded Generics Sales and Marketing
7.4.1 Branded Generics Sales Channels
7.4.2 Branded Generics Distributors
7.5 Branded Generics Customers
8 Branded Generics Market Dynamics
8.1 Branded Generics Industry Trends
8.2 Branded Generics Market Drivers
8.3 Branded Generics Market Challenges
8.4 Branded Generics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock